Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 886 — Ophthalmic Devices · § 886.1342

§ 886.1342. Strabismus detection device.

268 words·~1 min read·/us/cfr/t21/s§ 886.1342·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Identification. A strabismus detection device is a prescription device designed to simultaneously illuminate both eyes with polarized light for automated detection of strabismus by analyzing foveal birefringence properties.
(b)Classification. Class II (special controls). The special controls for this device are:
(1)Clinical performance testing must demonstrate the device performs as intended under anticipated conditions of use. Testing must be conducted in a representative patient population and clinical setting for the indicated use. Demonstration of clinical performance must include assessment of sensitivity and specificity compared to a clearly defined reference standard (e.g., comprehensive ophthalmological examination comprises age-appropriate visual acuity testing, examination of the external ocular adnexae and orbit, anterior segment evaluation, extraocular motility evaluation, assessment of stereopsis, cycloplegic refraction, and dilated fundus examination).
(2)Non-clinical performance testing must demonstrate the device performs as intended under anticipated conditions of use. The following technical characteristics must be evaluated:
(i)Verification of lowest detectable amount of deviation; and
(ii)Validation of the accuracy and precision at the lowest detectable amount of deviation.
(3)Software verification, validation, and hazard analysis must be performed.
(4)Optical radiation safety testing must demonstrate the device is safe per the directions for use.
(5)Performance testing must demonstrate the electromagnetic compatibility of the device.
(6)Performance testing must demonstrate the electrical safety of the device.
(7)Labeling must include the following:
(i)Summaries of non-clinical and clinical performance testing;
(ii)Instructions on how to correctly use and maintain the device;
(iii)Instructions and explanation of all user-interface components; and
(iv)Information related to electromagnetic compatibility and optical radiation classification. [81 FR 65280, Sept. 22, 2016]
Connections1 cite this
Cited by 1 section
Citation graph
cites case law
§ 886.1342
Strabismus detection device.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.